Vitamin D Supplementation and COVID-19 Outcomes: Mounting Evidence and Fewer Doubts.
Nutrients
; 14(17)2022 Aug 31.
Article
in English
| MEDLINE | ID: covidwho-2006148
ABSTRACT
The coronavirus disease 2019 (COVID-19) has already killed more than 6 million people around the world. A growing body of epidemiological evidence suggests that low 25-hydroxy vitamin D (25-OH-vitamin D) plasma levels are associated with an increased risk of developing COVID-19 and -most importantly-with a higher risk of developing more severe COVID-19 and dying. On the other hand, vitamin D supplementation during the early phases of COVID-19 has been related to a decreased length of hospital stay, less frequent need for oxygen, and a reduced mortality rate in inpatients. This seems to be particularly true when high dosages are used. In light of this evidence, further studies are needed to define the best timing for vitamin D supplementation and the most effective dosage schedule.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vitamin D Deficiency
/
COVID-19
Type of study:
Prognostic study
Topics:
Long Covid
/
Traditional medicine
Limits:
Humans
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Nu14173584
Similar
MEDLINE
...
LILACS
LIS